Glucose-Insulin-Potassium Infusion (GIK)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Glucose-Insulin-Potassium Infusion (GIK), covering 2026-03-05 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: Role of Combination Therapy of Glucose Insulin Potassium Infusion (GIK), Intravenous Hydrocortisone and Oral Sevelamer in Treatment of Acute Aluminum Phosphide Poisoned Cases Admitted to Intensive Care Unit (ICU) at Sohag University Hospitals. [NA]